The whole point here is that we're talking about a secular arc, not just a quarterly earnings call. Focusing on what was true for a few years with computer chips completely misses the generational shift happening in biotech; we're now able to sequence a whole human genome for less than the cost of a decent family car, which was unthinkable when Moore wrote his paper. The future of medicine isn't about incremental chip improvements, it's about this kind of structural inevitability.